1. Home
  2. KTCC vs OTLK Comparison

KTCC vs OTLK Comparison

Compare KTCC & OTLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Key Tronic Corporation

KTCC

Key Tronic Corporation

HOLD

Current Price

$3.76

Market Cap

36.8M

Sector

Technology

ML Signal

HOLD

Logo Outlook Therapeutics Inc.

OTLK

Outlook Therapeutics Inc.

HOLD

Current Price

$1.58

Market Cap

37.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KTCC
OTLK
Founded
1969
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.8M
37.5M
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
KTCC
OTLK
Price
$3.76
$1.58
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$2.50
AVG Volume (30 Days)
27.9K
32.7M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
55.91
EPS
N/A
N/A
Revenue
$467,871,000.00
$8,146,123.00
Revenue This Year
N/A
$1,430.98
Revenue Next Year
N/A
$173.23
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$0.16
52 Week High
$4.20
$3.39

Technical Indicators

Market Signals
Indicator
KTCC
OTLK
Relative Strength Index (RSI) 58.34 83.79
Support Level $2.57 $0.19
Resistance Level $4.20 $2.09
Average True Range (ATR) 0.30 0.18
MACD -0.01 0.08
Stochastic Oscillator 44.30 88.29

Price Performance

Historical Comparison
KTCC
OTLK

About KTCC Key Tronic Corporation

Key Tronic Corporation provides electronic manufacturing services, including engineering, materials management, manufacturing and assembly, in-house testing, and distribution to various countries. The company serves diverse industries such as pest control, personal protection, air purification, automotive, medical technology, and utilities inspection equipment. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly. Key Tronic operates manufacturing facilities in the United States, Vietnam, and Mexico, recently expanding with a new facility in Arkansas. Revenue is generated mainly through contract manufacturing and service agreement.

About OTLK Outlook Therapeutics Inc.

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an ophthalmic formulation of ONS-5010/LYTENAVA (bevacizumab-gamma) for use in treating wet age-related macular degeneration, or wet AMD, in the European Union, and United Kingdom. The product pipeline includes ONS-5010/LYTENAVA, which is in total eight NORSES; ONS-5010 Clinical Progress, Unmet Patient Needs, New Ophthalmic Anti-VEGF, and Potential First Line Therapy.

Share on Social Networks: